Patent application number | Description | Published |
20110041985 | METHOD AND APPARTUS FOR MANUFACTURING FIBRE-REINFORCED HOSES - The object of the invention is a method for building hoses reinforced with spirally laid fibres, where the hose under construction ( | 02-24-2011 |
20110068572 | SWAGED COUPLING FOR HIGH-PRESSURE HOSE, HIGH-PRESSURE HOSE WITH SWAGED COUPLING, AND METHOD FOR MAKING THE SAME - A hose coupling for high-pressure hoses includes a stem and a ridged outer ferrule connected to the stem, wherein a staggered portion is disposed on the stem in the proximity of the connection of the stem and the ridged outer ferrule, where the diameter of the staggered portion is larger than the diameter of the stem, and the staggered portion has an undercut and a cutting edge. Also, a high-pressure hose fitted with the above swaged coupling, and a method for producing it. In the method, prior to swaging, the cover of the hose is removed at the portion where the cover is in connection with the ridges of the ridged outer ferrule of the hose coupling, and the hose liner and an optionally included load distribution textile ply or cord fabric ply are also removed from the hose end before swaging at a length not longer than the length of the staggered portion of the stem. | 03-24-2011 |
20140261845 | BONDED HIGH-PRESSURE RUBBER HOSE, PARTICULARLY FOR CONVEYING GASEOUS MEDIA - The invention relates to a bonded high-pressure rubber hose comprising a flexible internal stripwound tube ( | 09-18-2014 |
20160003381 | FLEXIBLE METAL PIPE, METHOD AND APPARATUS FOR PRODUCING THE SAME, AND HOSE COMPRISING THE FLEXIBLE METAL PIPE - The invention relates to a flexible metal pipe spirally wound from profiled metal strips, wherein the width of the strip profiles is greater than the axial pitch measured at the direction of the principal axis of the flexible metal pipe, and the profiles may slide over one another as the flexible metal pipe is bent the essential feature of the invention being that the strip profile is made from at least two substantially or partially overlapping strips ( | 01-07-2016 |
Patent application number | Description | Published |
20090312001 | Providing subscriber identity for cell traffic trace in E-UTRAN - Embodiments of the invention include methods, apparatuses, systems and computer programs related to providing a cell traffic trace functionality in E-UTRAN. A cell trace activation message is received, a cell traffic trace session is then started for a cell, and call set up is started. A trace recording session is started and, simultaneously, a unique identifier is generated for the recording session. A trace notification may then be sent to a core network or mobility management entity. The trace notification may include a trace recording session reference which comprises the unique identifier for the recording session. The IMSI and/or IMEI may also be determined for the call, and the trace recording session reference is forwarded to a trace collection entity. | 12-17-2009 |
20120309431 | GEOGRAPHICAL DETERMINATION OF COVERAGE IN COMMUNICATIONS SYSTEMS - A method of determining geographical determination of coverage in a mobile communications system by obtaining measurement data provided by a plurality of mobile terminals the method comprising the steps of: requesting terminal capability information from the subscriber terminals in a cell; obtaining the terminal capability information from the subscriber terminals; comparing the terminal capability information with capability requirement information; selecting selected subscriber terminals on the basis of their capability information; sending a trace activation command to the selected subscriber terminals; and receiving measurement data measured by the selected subscriber terminals. | 12-06-2012 |
20130039196 | OPERATION AND MAINTENANCE OF A TELECOMMUNICATIONS NETWORK - A management system for managing the operation of network elements in a mobile communications system, the management system comprising: a manager agent entity being capable of sending a request for the network element to measure a parameter indicated by a target to obtain a plurality of measured parameters and being capable of sending an achievement indication element related to the target; and an agent entity being capable of receiving the achievement indication element and being capable of determining a target achievement indication in respect of at least one measured parameter, the target achievement indication having been determined as a result of monitoring the correspondence between the target and the at least one measured parameter. | 02-14-2013 |
20130051244 | NETWORK OPTIMISATION - A SON algorithm is described in which performance targets are defined and evaluated. The evaluation of a performance target includes using or setting an evaluation period defining a time period over which the performance target is evaluated and using or setting an evaluation frequency defining how often the performance target is evaluated. The performance targets are used for optimising a configuration of a mobile telecommunication system. | 02-28-2013 |
20130064120 | MEASUREMENT REPORTING IN COMMUNICATIONS SYSTEMS - A communications system comprises a managing entity responsible for handling measurement reports and a network node, the managing entity being capable of sending condition-related parameters to the network node and the network node being capable of controlling measurement reporting in a communications system by: receiving a measurement report from a mobile terminal; determining from the measurement report whether it is a type of measurement report for which condition-related parameters need to be applies; wherein if the measurement report is of the type requiring the condition-related parameters to be applied, applying a load-related condition and a security related condition and if both are satisfied, providing the measurement report to the managing entity. | 03-14-2013 |
20130109320 | Measurements Logging and Transmission at a User Equipment of a Mobile Communications System | 05-02-2013 |
20130137460 | Correlation of Collected Mobile Terminal Based Measurement Data and Positioning Data - A network control element receives position information data including a trace session identification parameter, the position information data including information about the position of a mobile terminal, and measurement data including the trace session identification parameter are received. The position information data is correlated with the measurement data based on the trace session identification parameter. | 05-30-2013 |
20130288664 | Terminal Measurement Configuration in Carrier Aggregation - There are provided measures for terminal measurement configuration in carrier aggregation, said measures exemplarily including a configuration of one or more carriers for automatic terminal measurements relating to network performance on said one or more carriers, said one or more carriers being carriers in a carrier aggregation for one or more terminals, wherein said configuration may be dependent on the one or more terminals' capabilities in terms of single- or multi-carrier terminal measurements. According to such configuration, automatic terminal measurements may be performed simultaneously on the configured one or more carriers or on the configured one or more carriers based on a predetermined priority of each carrier. Said measures may exemplarily be applied for in an MDT context. | 10-31-2013 |
20130290230 | METHOD FOR HETEROGENEOUS NETWORK POLICY BASED MANAGEMENT - Communication networks in general may benefit from appropriate policy based management. More particularly, heterogeneous networks or HetNets may benefit from methods for policy based management. A method according to certain embodiments includes detecting a reportable event. The method also includes determining whether or how to report the event based on a probability criterion. The method further includes taking an action with respect to reporting the event based on whether the probability criterion is met. | 10-31-2013 |
20130324106 | REPORTING IN COMMUNICATIONS SYSTEMS - A communication network comprises a management system, a core network element, and a radio access network element. The core network element may be a subscriber database or a mobility entity. It is capable of: receiving consent information; receiving from the management system a measurement reporting activation in a network; checking whether at least part of the activation request applies to a subscriber for whom consent information consenting to measurement reporting has been provided; and in the event that consent information consenting to measurement reporting has been provided, ensabling the activation request by communicating with the radio access network element so that measurement reporting in respect of that subscriber may take place. The measurement reporting activation may be for subscriber-based or area-based measurements to be made. | 12-05-2013 |
20140024366 | EXCLUDING ROAMING USERS FROM AREA BASED MDT DATA TRANSMISSION - It is provided an apparatus, comprising base station means adapted to provide a base station functionality of a visited mobile network; selecting means adapted to select a user equipment, which is operably connected to the base station means, to report a result of a predefined measurement to the apparatus, wherein the selecting means is adapted to select the user equipment only if a roaming information of the user equipment received from a mobility management entity by which mobility of the user equipment is controlled indicates that a user of the user equipment is subscribed to one of one or more predefined mobile networks. | 01-23-2014 |
20140043982 | CORRELATING RADIO LINK FAILURE AND MINIMIZATION OF DRIVE TEST REPORTS - Various communication systems may benefit from appropriate correlation of failure reports. For example, communication systems of the third generation partnership project (3GPP) may benefit from correlating radio link failure and minimization of drive test reports, particularly with respect to self-organized networks mobility robustness optimization. | 02-13-2014 |
20140349583 | MINIMIZATION OF DRIVE TESTS DATA AND RADIO LINK FAILURE INFORMATION CORRELATION - A method, apparatus, system, and computer-readable medium is provided for performing RLF functionality within a trace functionality. As part of trace functionality, RLF information, in the form of one or more RLF reports, is collected. When MDT information is also collected as part of trace functionality, the RLF information and the MDT information is correlated. | 11-27-2014 |
20150045014 | METHOD AND APPARATUS FOR USE IN MDT DATA COLLECTION - According to an embodiment there is provided a method comprising; collecting a first type of measurement and a second type of measurement, said first and second types of measurement being used together by an entity; and causing values of said first type of measurement to be sent with associated values of said second type of measurement to be sent. | 02-12-2015 |
20150249930 | RADIO LINK FAILURE REPORT FILTERING - Embodiments of the invention include a method for collecting RLF data in a wireless network. The method may include receiving, by a first radio access node, RLF data related to a connection failure experienced by a UE. The method may then include determining whether the RLF data satisfies at least one condition and, when it is determined that the RLF data satisfies the at least one condition, sending the RLF data to at least one of a second radio access node and an RLF data collection entity. In one embodiment, the RLF data may be received from a second radio access node or the UE. | 09-03-2015 |
20150334645 | TRACING INTER-RAT EVENTS - It is provided an apparatus, comprising selecting means adapted to select one set of parameters/values out of a first set of parameters/values and a second set of parameters/values received in an activation message related to a trace session of a subscriber or a terminal, wherein the selected set of parameters/values corresponds to the trace session in a first domain of the apparatus and the other set of parameters/values corresponds to the trace session in a second domain different from the first domain; providing means adapted to provide the selected set of parameters/values and an identifier to a tracing device for performing the trace session in the first domain, wherein the identifier is received in the activation message and related to the trace session. | 11-19-2015 |
Patent application number | Description | Published |
20150252400 | GLYCOCONJUGATE SYNTHESIS - The invention relates to a method for producing a glycoconjugate comprising an oligosaccharide part covalently linked to a non-sugar moiety selected from the group consisting of amino acids, peptides, proteins, lipids, longer alkyl groups, polyethylene glycols, α,β-unsaturated amido group and polyvinyl alcohols, using a genetically modified cell. | 09-10-2015 |
20150320780 | MIXTURE OF FUCOSYLATE LACTOSES - A method to form a mixture containing at least one of 2′-FL (2′-O-fucosyllactose, Fuc(α1-2)Gal(β1-4)Glc) and 3-FL (3-O-fucosyllactose, Gal(β1-4)[Fuc(α1-3)]Glc) characterized in that DFL (difucosyl-lactose, Fuc(α1-2)Gal(β1-4)[Fuc(α1-3)]Glc) is subjected to partial hydrolysis, e.g. enzymatic hydrolysis or acid hydrolysis. | 11-12-2015 |
20150329580 | NOVEL POLYMORPHS OF LNNT - A crystalline LNnT polymorph IV, characterized in that it displays X-ray powder diffraction reflections, based on a measurement using CuKα radiation, at 8.16, 15.41, 39.14, 23.77, 7.77 and 31.15 2Θ angles, and a crystalline LNnT polymorph V, characterized in that it displays X-ray powder diffraction reflections, based on a measurement using CuKα radiation, at 9.15, 10.26, 19.68, 26.06, 20.61 and 1 1.89 2Θ angles, are provided. | 11-19-2015 |
Patent application number | Description | Published |
20100261873 | GLYCOPROTEINS AND GLYCOSYLATED CELLS AND A METHOD FOR THE PREPARATION OF THE SAME - The present application discloses novel glycoproteins and a related glycosylcarbamoylation methodology suitable for the preparation of glycopeptides (in particular glycoproteins and glycosylated cells), as well as the use of such glycoproteins in medicine, e.g. as pharmaceuticals and diagnostics or in diagnostic kits. The method for the preparation of a carbohydrate-peptide conjugate comprises reacting a cyclic carbamate (1) (wherein R | 10-14-2010 |
20110166339 | CRYSTALLINE CARBOHYDRATE DERIVATIVE - α-Lactosamine hydrochloride, substantially free of β-lactosamine hydrochloride; a method of preparing α-lactosamine hydrochloride monohydrate from an anomeric mixture of lactosamine hydrochloride, including: preparing a solution including the anomeric mixture of lactosamine hydrochloride, water and at least one water-miscible organic solvent at a temperature of 0-100° C., and cooling the solution to cause crystallisation of α-lactosamine hydrochloride monohydrate; a method of preparing anhydrous α-lactosamine hydrochloride; and use of α-lactosamine hydrochloride as a food supplement or intermediate in synthesis. | 07-07-2011 |
20130171696 | SYNTHESIS OF NEW SIALOOLIGOSACCHARIDE DERIVATIVES - The invention relates to a method for the synthesis of compounds of general formula (1A) and salts thereof wherein one of the R groups is an α-sialyl moiety and the other is H, X | 07-04-2013 |
20130172548 | DERIVATIZATION OF OLIGOSACCHARIDES - A method for purifying, separating and/or isolating an oligosaccharide or a salt thereof is presented. An embodiment of the invention is based upon the formation of anomeric O-benzyl/substituted O-benzyl derivatives in a selective anomeric alkylation reaction. | 07-04-2013 |
20130245250 | METHOD FOR PRODUCING L-FUCOSE - Method for producing L-fucose includes in a first aspect, a method for the preparation of L-fucose, wherein L-fucose precursors are produced from pectin and L-fucose is produced from the L-fucose precursors; in a second aspect, a method for the preparation of L-fucose from D-galacturonic acid or a salt thereof, wherein L-fucose precursors are produced from D-galacturonic acid of a salt thereof, and L-fucose is produced from the L-fucose precursors; and an L-fucose precursor as shown in Formula A, wherein R is a linear or branched chain saturated hydrocarbon group with 1-6 carbon atoms, such as methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, s-butyl, t-butyl, n-hexyl, etc., preferably a methyl group. | 09-19-2013 |
20140235840 | NEW SYNTHESIS OF FUCOSE - A process for converting D-glucose into L-fucose, where a first aspect of the disclosure relates to a method of making a compound of formula (1) wherein R is independently H, alkyl or phenyl or, preferably, wherein the two germinal R groups together with the carbon atom to which they are attached form a C3-s cycloalkylidene group, including the step of treating a compound of formula (2) wherein R is defined above and R | 08-21-2014 |
20140235850 | SYNTHESIS OF HMO CORE STRUCTURES - The invention relates to a method for making precursors of HMO core structures comprising a step of reacting an N-acetyllactosamine or lacto-N-biose derivative donor with a lactose or N-acetyllactosamine derivative acceptor, wherein the donor is an oxazoline donor. | 08-21-2014 |
20140248415 | NUTRITIONAL PRODUCTS COMPRISING HUMAN MILK OLIGOSACCHARIDES AND METHODS FOR MANUFACTURE THEREOF - A method for the manufacture an infant formula or an infant nutritional product comprising mixture of human milk oligosaccharides is disclosed. The method involves the catalytic hydrogenolysis of compounds of the general formula 1 and 2 with particular oligosaccharide profiles. | 09-04-2014 |
20150291642 | CRYSTALLINE 3-O-FUCOSYLLACTOSE - Crystalline 3-O-fucosyllactose, useful in a pharmaceutical composition and a nutritional formulation, is disclosed. | 10-15-2015 |
Patent application number | Description | Published |
20110060139 | CARBOHYDRATE DERIVATIVES - A 1,2-dideoxy-1,2-diamino oligosaccharide or polysaccharide in its free base, salt or metal-complex form as shown in General Formula 1 and derivative thereof is described. | 03-10-2011 |
20120309949 | METHOD FOR PREPARATION OF THE TETRASACCHARIDE LACTO-N-NEOTETRAOSE (LNNT) CONTAINING N-ACETYLLACTOSAMINE - The present invention relates to a method for preparation of the tetrasaccharide lacto-N-neotetraose (LNnt, formula (I)) especially in large scale, as well as intermediates in the synthesis, a new crystal form (polymorph) of LNnt, and the use thereof in pharmaceutical or nutritional compositions. | 12-06-2012 |
20130035481 | PRODUCTION OF 6'-O-SIALYLLACTOSE AND INTERMEDIATES - The present invention relates to a method for preparation of the trisaccharide 6′-0-sialyllactose (formula (I)) or salts thereof as well as intermediates in the synthesis and for the use of 6′-0-sialyllactose salts in pharmaceutical or nutritional compositions. | 02-07-2013 |
20130072675 | METHOD FOR CYRSTALLIZATION OF FUCOSE - The present application discloses a method for the crystallization of fucose, characterized in that the crystallization is carried out from a mixture comprising fucose and at least one 6-deoxy sugar selected from 6-deoxy-talose and 6-deoxy-gulose. In one embodiment, the mixture comprises fucose and 6-deoxy-talose. | 03-21-2013 |
20130131334 | METHOD FOR THE SYNTHESIS OF A TRISACCHARIDE - The present invention relates to an improved synthesis of a trisaccharide of the formula (1), novel intermediates used in the synthesis and the preparation of the intermediates. | 05-23-2013 |
20130165406 | POLYMORPHS OF 2'-O-FUCOSYLLACTOSE AND PRODUCING THEREOF - The present invention relates to novel polymorphs of the trisaccharide 2′-O-fucosyllactose (2-FL) of formula (1), methods for producing said polymorphs and their use in pharmaceutical or nutritional compositions. | 06-27-2013 |
20140046044 | NOVEL GLYCOSYL PHOSPHITES - The present invention relates to providing compounds of general formula 1 | 02-13-2014 |
20140046051 | N-SUBSTITUTED MANNOSAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE - A compound of the formula (1) wherein R | 02-13-2014 |
20140057868 | CATALYTIC HYDROGENOLYSIS OF A COMPOSITION OF A MIXTURE OF OLIGOSACCHARIDE PRECURSORS AND USES THEREOF - A method for the manufacture of a mixture of human milk oligosaccharides is disclosed. The method involves the catalytic hydrogenolysis of compounds of the general formula 1 and 2. The use of compounds of general formula 1 and 2 in the manufacture of human milk oligosaccharides is also disclosed. | 02-27-2014 |
20140212930 | DIVERSIFICATION OF HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF - A method of diversification of human milk oligosaccharides (HMOs) or precursors thereof, compounds obtainable by the method, and uses and compositions involving such compounds. The method comprises a) providing at least one compound or a mixture of the compounds selected from the group consisting of: optionally sialylated and/or fucosylated lactose derivatives of general formula 2 and salts thereof; b) adding at least one enzyme comprising a transglycosidase activity to the at least one compound or a mixture of compounds provided according to step a); and c) incubating the mixture obtained according to step b). | 07-31-2014 |
20140234912 | METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF - A method for generating human milk oligosaccharides (HMOs) or precursors thereof, compounds obtainable by the method, and uses and compositions involving such compounds. The method comprising the steps of a) providing at least one donor selected from the group of compounds of any of formulae 5 to 10, b) providing at least one acceptor from a group of lactose, LNT, LNnT and derivatives thereof, c) providing at least one enzyme comprising a transglycosidase activity and/or a glycosynthase activity, d) preparing a mixture of the at least one donor, at least one acceptor and at least one enzyme provided in steps a), b) and c); and e) incubating the mixture prepared according to step d). | 08-21-2014 |
20140235848 | METHOD FOR MAKING A PRECURSOR OF L-FUCOSE FROM D-GLUCOSE - A method that can be used to make a precursor of L-fucose from D-glucose that includes the steps of a) making a compound of formula (1) from D-glucose, formula (1) wherein R | 08-21-2014 |
20140303363 | Preparation and Use of Isolactosamine and Intermediates therefor - The invention relates to providing isolactosamine (Galβ1-3GlcNH | 10-09-2014 |
20140323705 | MANUFACTURE OF LACTO-N-TETRAOSE - The present invention relates to the synthesis of the tetrasaccharide of formula (I) and novel intermediates used in the synthesis. | 10-30-2014 |
20140349347 | SYNTHESIS OF N-ACETYL-D-NEURAMINIC ACID - Method of making NANA from NAM, which may itself be made from fructose. The NAM is treated with pyruvic acid or a pyruvate in the presence of a NANA aldolase having at least 70% sequence similarity or homology to the amino acid sequence of SEQ. ID. NO. 1. | 11-27-2014 |
20140378679 | CRYSTALLINE CARBOHYDRATE DERIVATIVE - α-Lactosamine hydrochloride, substantially free of β-lactosamine hydrochloride; a method of preparing α-lactosamine hydrochloride monohydrate from an anomeric mixture of lactosamine hydrochloride, including: preparing a solution including the anomeric mixture of lactosamine hydrochloride, water and at least one water-miscible organic solvent at a temperature of 0-100° C., and cooling the solution to cause crystallisation of α-lactosamine hydrochloride monohydrate; a method of preparing anhydrous α-lactosamine hydrochloride; and use of α-lactosamine hydrochloride as a food supplement or intermediate in synthesis. | 12-25-2014 |
20150065702 | Synthesis of the Trisaccharide 3-O-Fucosyllactose and Intermediates Thereof - 3-O-Fucosyllactose is made by process which includes the hydrogenolysis of a new compound of the formula 1 wherein R | 03-05-2015 |
20150133647 | Method for Producing Oligosaccharides and Oligosaccharide Glycosides by Fermentation - The application discloses a method for producing anomerically protected glycosidic oligosaccharide derivatives comprising the step of culturing, in a culture medium containing an anomerically protected lactose acceptor, a genetically modified cell having a recombinant gene that encodes a glycosyl transferase that can transfer a glycosyl residue of an activated sugar nucleotide to said lactose acceptor. The application further discloses a method for producing an oligosaccharide comprising the steps of: (a) culturing, in a culture medium containing an anomerically protected lactose acceptor, a genetically modified cell having a recombinant gene that encodes a glycosyl transferase that can transfer a glycosyl residue of an activated sugar nucleotide to said lactose acceptor to produce an anomerically protected glycosidic oligosaccharide derivative, then (b) removing/deprotecting the anomeric protective group. | 05-14-2015 |
20150182549 | METHOD FOR ENZYMATIC GLYCOSYLATION OF OLIGOSACCHARIDES FROM MAMMALIAN ANIMAL MILK - A method for modifying galactosyl disaccharides in order to enhance their bifidogenic effect, comprising reacting at least one glycosyl donor with a precursor galactosyl disaccharide or a mixture of precursor galactosyl disaccharides using enzyme catalysis, compounds obtainable by said method and the use of such compounds in consumable products. | 07-02-2015 |
20150183814 | Enhancing the Stability and Purity and Increasing the Bioavailability of Human Milk Oligosaccharides or Precursors or Blends Thereof - The present application discloses a method for enhancing the stability of a human milk oligosaccharide (HMO) or a HMO precursor or a HMO blend when stored for extended periods at temperatures above 25° C. by spray-drying an aqueous solution of the HMO or HMO precursor to remove at least 90% of the water and providing a HMO or a HMO precursor or a HMO blend with a specific glass transition temperature. Also disclosed is a method for removing organic solvent residues from a human milk oligosaccharide (HMO) or a HMO precursor or a HMO blend by spray drying. Also disclosed is a method of enhancing the bioavailability of a human milk oligosaccharide (HMO) or a HMO precursor or a HMO blend by spray drying. | 07-02-2015 |
20150183816 | MODIFIED GALACTOOLIGOSACCHARIDES - The invention relates to a method for making modified galactooligosaccharides comprising the step of enzymatic glycosylation, the modified galactooligosaccharides obtainable by the method and consumable products containing them. | 07-02-2015 |
20150239923 | SYNTHESIS OF A TETRASACCHARIDE CONTAINING N-ACETYLLACTOSAMINE - The present invention relates to the synthesis of the tetrasaccharide of formula (I) and novel intermediates used in the synthesis. | 08-27-2015 |
20150329579 | METHOD FOR MAKING N-SUBSTITUTED MANNOSAMINE DERIVATIVES - A method for making an N-substituted D-mannosamine derivative of the following formula 1 and its salts | 11-19-2015 |
20160024129 | SYNTHESIS OF NEW SIALOOLIGOSACCHARIDE DERIVATIVES - The invention relates to a method for the synthesis of compounds of general formula (1A) and salts thereof wherein one of the R groups is an α-sialyl moiety and the other is H, X | 01-28-2016 |
20160075729 | SYNTHESIS OF SIALYLATED/FUCOSYLATED HUMAN MILK OLIGOSACCHARIDES - An achemo-enzymatic synthesis of oligosaccharides of formula 1 is presented wherein R is selected from —OH, —N3 and —OR6 wherein R6 is selected from allyl optionally substituted by one or more methyl, propargyl optionally substituted by one or more methyl, 2-trimethylsilyl-ethyl, —(CH2)n—NH2 and —(CH2)n—N3 wherein integer n is to 10, preferably 2 or 3, R is selected from sialyl moiety, —SO3H and —CH(R)—COOH wherein R is selected from H, alkyl and benzyl, R2 is selected from H and fucosyl, R3 is selected from H and sialyl, R4 is selected from H and fucosyl, provided that at least one of R3 and R4 is H, and A is a divalent carbohydrate linker, having important biological activities and significant commercial value for the pharmaceutical and food industry. | 03-17-2016 |
Patent application number | Description | Published |
20090215757 | Process for Preparation of High-Purity Meloxicam and Meloxicam Potassium Salt - The invention provides a process for the preparation of high purity meloxicam of the Formula (II). The meloxicam raw product is reacted with the solution of potassium hydroxide or potassium carbonate, whereby high purity meloxicam potassium salt monohydrate is produced. Said salt is subsequently treated with mineral or organic acid to yield high-purity meloxicam. | 08-27-2009 |
20100286404 | PHARMACEUTICAL INTERMEDIATES IN THE SYNTHESIS OF ACE-INHIBITORS AND THE USE THEREOF - The compounds of the general Formula (I), wherein R | 11-11-2010 |
20110040093 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL INTERMEDIATE - The invention relates to a process for the preparation of compounds of general formula (III), wherein R represents fluorine or chlorine atom and X represents chlorine or bromine atom, by halogenation of cyclopropyl benzyl ketone of general formula (II), wherein R represents fluorine or chlorine atom and the halogenation is carried out in the mixture of aqueous hydrogen halide and aqueous hydrogen peroxide in the presence of a water miscible solvent or in the presence of a phase transfer catalyst; or the halogenation is carried out in the mixture of sulfuric acid and an alkali metal salt of aqueous hydrogen halide. The process can be applied preferably on industrial scale. | 02-17-2011 |
20120035162 | PROCESS FOR PREPARATION OF HIGH-PURITY MELOXICAM AND MELOXICAM POTASSIUM SALT - The invention provides a process for the preparation of high purity meloxicam of the Formula (II). The meloxicam raw product is reacted with the solution of potassium hydroxide or potassium carbonate, whereby high purity meloxicam potassium salt monohydrate is produced. Said salt is subsequently treated with mineral or organic acid to yield high-purity meloxicam. | 02-09-2012 |
20130225695 | METHOD FOR PREPARATION OF AN EXCIPIENT SUITABLE FOR PHARMACEUTICAL USE - The present invention is related to a method for purifying diatomaceous earth wherein the natural colloidal structure of the material is retained, which comprises preparing a suspension of diatomaceous earth in a liquid wherein diatomaceous earth is insoluble, separating diatomaceous earth from the suspension, treating diatomaceous earth with an inorganic or organic acid, heat-treating the thus obtained product at a temperature not higher than 300° C., subjecting the product obtained to oxidative treatment and drying the purified product. | 08-29-2013 |